ClassID:

94861

C07D295/073 - CPC Classification

Classification description:

Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Recent Application in this class:
#1
20250282790
2025-09-11

NOVEL MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE

#2
20250250244
2025-08-07

DEUTERATED 1-PIPERAZINO-3-PHENYL INDANES FOR TREATMENT OF SCHIZOPHRENIA

#3
20250025443
2025-01-23

COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES

#4
20240327354
2024-10-03

GRAM-NEGATIVE BACTERIA EFFLUX PUMP INHIBITORS

#5
20230348358
2023-11-02

Serotonin Receptor Modulators

#6
20230339874
2023-10-26

PIPERAZINYL COMPOUNDS AND METHODS FOR TREATING NEMATODE INFECTIONS

#7
20230159524
2023-05-25

METHODS FOR SYNTHESIZING N-(PHENYLSULFONYL)BENZAMIDE COMPOUNDS AND INTERMEDIATES THEREOF

#8
20230150924
2023-05-18

NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND

#9
20230133132
2023-05-04

NAMPT MODULATORS

#10
20230112888
2023-04-13

NOVEL MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE

#11
20220204464
2022-06-30

Method for fluoroalkylation of enamines

#12
20220119362
2022-04-21

Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia

#13
20210332046
2021-10-28

NICOTINIC ACETYLCHOLINE RECEPTOR SILENT AGONISTS

#14
20210238189
2021-08-05

Modulators of the 5-hydroxytryptamine receptor 7 and their method of use

#15
20210032214
2021-02-04

Compounds for binding proprotein convertase subtilisin/kexin type 9

#16
20200247804
2020-08-06

Nicotinic acetylcholine receptor silent agonists

#17
20200131143
2020-04-30

Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia

#18
20190367528
2019-12-05

Modulators of the 5-hydroxytryptamine receptor 7 and their method of use

#19
20190345122
2019-11-14

Methods for forming aryl carbon-nitrogen bond using light

#20
20190194163
2019-06-27

Dual NAV1.2/5HT2a inhibitors for treating CNS disorders

#21
20190119236
2019-04-25

COMPOUNDS FOR BINDING PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)

#22
20190054198
2019-02-21

Catalytic radiofluorination

#23
20190040028
2019-02-07

ARYLATION OF ALIPHATIC AMINES

#24
20190040027
2019-02-07

Synthesis of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine

#25
20190031631
2019-01-31

Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia

#26
20180298002
2018-10-18

Nicotinic acetylcholine receptor silent agonists

#27
20180291013
2018-10-11

COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND RELATED DISORDERS

#28
20180264448
2018-09-20

Ni(0) catalysts

#29
20180251472
2018-09-06

Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same

#30
20180208566
2018-07-26

Deuterated Meclizine

#31
20170305886
2017-10-26

Plant growth-promotion agent and method for promoting plant growth

#32
20170240521
2017-08-24

PERIPHERALLY-ACTING CANNABINOID RECEPTOR AGONISTS FOR CHRONIC PAIN

#33
20170226072
2017-08-10

1,4-Disubstituted Piperidines, 1,4-Disubstituted Piperazines, 1,4-Disubstituted Diazepines, and 1,3-Disubstituted Pyrrolidine Compounds

#34
20170158675
2017-06-08

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

#35
20170158674
2017-06-08

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

#36
20170158650
2017-06-08

Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia

#37
20170137341
2017-05-18

Fluorination method

#38
20170020866
2017-01-26

Treatment of parkinson's disease through ARFGAP1 inhibition

#39
20170001988
2017-01-05

PIPERIDINE AND PIPERAZINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS AND CANCER

#40
20160193215
2016-07-07

Compounds as HIF-1α inhibitors and manufacturing process thereof

#41
20160068497
2016-03-10

Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia

#42
20160039745
2016-02-11

Histone deacetylase inhibitors and compositions and methods of use thereof

#43
20160024063
2016-01-28

3-(4-(benzyloxy)phenyl)hex-4-ynoic acid derivative, method of preparing same and pharmaceutical composition for preventing and treating metabolic disease including same as effective ingredient

#44
20150336867
2015-11-26

6-chloro-3-(phenyl-d5)-inden-1-one and use thereof

#45
20150307501
2015-10-29

Compositions and Methods for the Treatment of Metabolic and Related Disorders

#46
20150283273
2015-10-08

Catalytic radiofluorination

#47
20150239859
2015-08-27

Peripherally-acting cannabinoid receptor agonists for chronic pain

#48
20150158831
2015-06-11

Substituted indenes as medicaments

#49
20150132223
2015-05-14

Catalytic radiofluorination

#50
20150057443
2015-02-26

Cycloalkyl Amine Compounds

#51
20140249161
2014-09-04

Stilbene analogs and methods of treating cancer

#52
20140228357
2014-08-14

Compounds as HIF-1alphainhibitors and manufacturing process thereof

#53
20140045851
2014-02-13

Morpholines as selective inhibitors of cytochrome P450 2A13

#54
20140005186
2014-01-02

Androgen receptor modulator compounds and methods

#55
20130289270
2013-10-31

Amination of aryl alcohol derivatives

#56
20130281436
2013-10-24

Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia

#57
20130225561
2013-08-29

Inhibitors of the renal outer medullary potassium channel

#58
20130203727
2013-08-08

Naphth-2-ylacetic acid derivatives to treat AIDS

#59
20130115168
2013-05-09

Catalytic radiofluorination

#60
20130072488
2013-03-21

Aralkyl diamine derivatives and uses thereof as antidepressants

#61
20120329649
2012-12-27

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

#62
20120322811
2012-12-20

Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophrenia

#63
20120207677
2012-08-16

Catalytic radiofluorination

#64
20120202994
2012-08-09

Method for carrying out chemical reactions with the aid of an inductively heated heating medium

#65
20120196874
2012-08-02

Stilbene analogs and methods of treating cancer

#66
20120129889
2012-05-24

Non-competitive NMDA receptor antagonists

#67
20120129870
2012-05-24

PIPERAZINYL DERIVATIVES USEFUL AS MODULATORS OF THE NEUROPEPTIDE Y2 RECEPTOR

#68
20120071651
2012-03-22

Processes for preparing 1,2-substituted cyclopropyl derivatives

#69
20120015911
2012-01-19

Method and compositions for treating amyloid-related diseases

#70
20110313158
2011-12-22

Two Component Recyclable Heterogeneous Catalyst, Process for Preparation Thereof and its Use for Preparation of Amines

#71
20110269775
2011-11-03

Piperazine derivatives

#72
20110237601
2011-09-29

Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists

#73
20110218205
2011-09-08

Piperazine derivatives

#74
20110184174
2011-07-28

Processes for the synthesis of levocetirizine and intermediates for use therein

#75
20110172425
2011-07-14

NOVEL WATER BASED PROCESS FOR THE PREPARATION OF SUBSTITUTED DIPHENYLMETHYL PIPERAZINES

#76
20110144120
2011-06-16

Phenyl-alkyl piperazines having TNF-modulating activity, preparation method, and therapeutic use thereof

#77
20110118464
2011-05-19

HALOGENATED XANTHINE DERIVATIVES AND PRECURSORS THEREOF FOR ANTI-CANCER AND ANTI-METASTASIS ACTIVITY AND PREPARING METHOD THEREOF

#78
20110098285
2011-04-28

Bicyclic-substituted amines as histamine-3 receptor ligands

#79
20110053957
2011-03-03

Malonate salt of 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and uses of same

#80
20110041263
2011-02-24

Azomethine direct dyes or reduced precursors of azomethine direct dyes obtained from 2-alkylresorcinols, and hair dyeing process using these dyes or precursors

#81
20100324291
2010-12-23

Processes for 4-((1R,35)-6-Chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine or a salt thereof

#82
20100324288
2010-12-23

Dihydropteridinone compounds

#83
20100256213
2010-10-07

Tosylate salt of trans-N-isobutyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-yl-methyl)-phenyl] cyclobut anecarboxamide

#84
20100249404
2010-09-30

Method for Carrying Out Chemical Reactions with the Aid of an Inductively Heated Heating Medium

#85
20100234391
2010-09-16

N-substituted piperazines

#86
20100215578
2010-08-26

Catalytic radiofluorination

#87
20100127210
2010-05-27

Liquid crystal compounds and liquid crystal compositions comprising the same

#88
20100113431
2010-05-06

N-METHYL PIPERAZINE MODULATORS OF H1 RECEPTOR

#89
20100105699
2010-04-29

Crystalline base of trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine

#90
20100081660
2010-04-01

Novel Compounds Having Selective Inhibiting Effect at GSK3

#91
20100069676
2010-03-18

PROCESS FOR MAKING TRANS-1-((1R,3S)-6-CHLORO-3-PHENYLINDAN-1-YL)-3,3-DIMETHYLPIPERAZINE

#92
20090281318
2009-11-12

Process for preparation of substantially optically pure levorotatory and dextrorotatory enantiomers of cetirizine using novel intermediates

#93
20090264435
2009-10-22

Novel Aryl- and Heteroarylpiperazines

#94
20090239873
2009-09-24

Phenyl-piperazine derivatives as modulators of muscarinic receptors

#95
20090221823
2009-09-03

Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates

#96
20090163547
2009-06-25

Indene derivatives, their preparation and use as medicaments

#97
20090143395
2009-06-04

Piperazine derivatives

#98
20090137592
2009-05-28

Morpholines as selective inhibitors of cytochrome P450 2A13

#99
20090054420
2009-02-26

Bicyclic-substituted amines as histamine-3 receptor ligands

#100
20080317806
2008-12-25

Antiparasitic Compounds

#101
20080293944
2008-11-27

Piperazinyl compounds

#102
20080269248
2008-10-30

Tartrate and Malate Salts of Trans-1-((1R,3S)-6-Chloro-3-Phenylindan-1-Yl)-3,3-Dimethylpiperazine

#103
20080269217
2008-10-30

Melanocortin-4 receptor binding compounds and methods of use thereof

#104
20080255137
2008-10-16

N-Biaryl and N-Arylheteroaryl 2-Substituted Piperazine Derivatives as Modulators of the 5ht2c Receptor Useful for the Treatment of Disorders Related Thereto

#105
20080200474
2008-08-21

NOVEL FLUNARIZINE SALT FORMS AND METHODS OF MAKING AND USING THE SAME

#106
20080176856
2008-07-24

Novel Alkyl Substituted Piperidine Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors

#107
20080171747
2008-07-17

Intermediate compounds for making dihydropteridinones useful as pharmaceutical compositions and processes of making the same

#108
20080153848
2008-06-26

Crystalline base of -1-(()-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine

#109
20080153847
2008-06-26

Process for making trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine

#110
20080135803
2008-06-12

High dielectric anisotropy liquid crystal compound and composition containing the same

#111
20080119477
2008-05-22

N-Biaryl and N-Arylheteroaryl Piperazine Derivatives as Modulators of the 5Ht2c Receptor Useful For the Treatment of Disorders Related Thereto

#112
20080103135
2008-05-01

Phenylalkynes

#113
20080096876
2008-04-24

Phenylalkynes

#114
20080045708
2008-02-21

New Process for the Synthesis of Morpholinylbenzenes

#115
20080039498
2008-02-14

Non-competitive NMDA receptor antagonists

#116
20080032979
2008-02-07

Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors

#117
20080009489
2008-01-10

ANDROGEN RECEPTOR MODULATORS AND METHOD OF TREATING DISEASE USING THE SAME

#118
20070254875
2007-11-01

Androgen receptor modulator compounds and methods

#119
20070191340
2007-08-16

Compounds which modulate the CB2 receptor

#120
20070179155
2007-08-02

N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases

#121
20070142400
2007-06-21

Enantjomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine

#122
20070112002
2007-05-17

1,2-di(cyclic)substituted benzene compounds

#123
20070105870
2007-05-10

Piperazine derivatives which exhibit activity as serotonin and noradrenaline re-uptake inhibitors

#124
20070072837
2007-03-29

Phenylalkynes

#125
20070004750
2007-01-04

N-substituted piperazines

#126
20060287298
2006-12-21

Pharmaceutical for treatment of neurological and neuropsychiatric disorders

#127
20060281759
2006-12-14

Hydrogen succinate salts of trans-4-((1R, 3S)-6-chloro-3-phenylindan-1-YL)-1,2,2-trimethylpiperazine and the use as a medicament

#128
20060281758
2006-12-14

-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine

#129
20060276465
2006-12-07

1,2-di(cyclic) substituted benzene compounds

#130
20060264673
2006-11-23

Copper-catalyzed formation of carbon-heteroatom and carbon—carbon bonds

#131
20060258859
2006-11-16

Phenylalkynes

#132
20060252934
2006-11-09

Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl]piperazine

#133
20060235024
2006-10-19

Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists

#134
20060229320
2006-10-12

Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine

#135
20060229319
2006-10-12

Enantiomers of 1-[(4-chlorophenyl) phenylmethyl)-4-[(4-methylphenyl)sulfonyl] piperazine

#136
20060223855
2006-10-05

Methods and compositions for treating amyloid-related diseases

#137
20060194798
2006-08-31

Bicyclic-substituted amines as histamine-3 receptor ligands

#138
20060173044
2006-08-03

Substituted propargylamines

#139
20060173014
2006-08-03

Compounds having selective inhibiting effect at GSK3

#140
20060172994
2006-08-03

Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists

#141
20060148815
2006-07-06

4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives

#142
20060135531
2006-06-22

Modulators of dopamine neurotransmission

#143
20060106067
2006-05-18

Fused benzene derivative and use

#144
20060025411
2006-02-02

Methods for treating diseases or conditions using dihydropteridinone compounds

#145
20060014739
2006-01-19

Androgen receptor modulators and method of treating disease using the same

#146
20060009456
2006-01-12

Aryl-substituted piperazine derivatives

#147
20050288304
2005-12-29

Tetrahydronaphthylpiperazines as 5HT1B antagonists, inverse agonists and partial agonists

#148
20050261291
2005-11-24

1,2-di(cyclic)substituted benzene compounds

#149
20050250791
2005-11-10

Process for preparing monoarylpiperazines

#150
20050245543
2005-11-03

Histamine-3 receptor antagonists

#151
20050239799
2005-10-27

1-phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands

#152
20050234058
2005-10-20

Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use

#153
20050215794
2005-09-29

Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds

#154
20050203100
2005-09-15

Use of an alfa2-adrenoreceptor antagonist for cns-related diseases

#155
20050182070
2005-08-18

Method for the treatment of allergic conditions

#156
20050182069
2005-08-18

Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine

#157
20050176732
2005-08-11

Enantiomers of 1-(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine

#158
20050171115
2005-08-04

Alkanol and cycloalkanol-amine derivatives and methods of their use

#159
20050137211
2005-06-23

Phenyl-piperazine derivatives as modulators of muscarinic receptors

#160
20050137210
2005-06-23

Substituted n-aryl amidines as selective D dopamine receptor antagonists for the treatment of obesity and CNS disorders

#161
20050080090
2005-04-14

Naphthalene derivatives

#162
20050049146
2005-03-03

Use of substituted dibenzothiepine derivatives as insecticidal, acaricidal and nematicidal agents

#163
20050020576
2005-01-27

Kappa agonist compounds and pharmaceutical formulations thereof

#164
20050014761
2005-01-20

Intermediate compounds for making dihydropteridinones useful as pharmaceutical compositions

#165
20050014760
2005-01-20

Methods of treating diseases or conditions using dihydropteridinone compounds

#166
20050010045
2005-01-13

Process for the synthesis of morpholinylbenzenes